Earnings Feed
Sign Up
Home/Filings/4/0001415889-24-024866
4//SEC Filing

Ho William Tai-Wei 4

Accession 0001415889-24-024866

CIK 0001740279other
View on SEC.govCompany Profile

Filed

Oct 7, 8:00 PM ET

Accepted

Oct 8, 4:15 PM ET

Size

16.2 KB

Accession

0001415889-24-024866

Insider Transaction Report

Form 4
Period: 2024-10-04
IN8BIO, INC.INAB
Ho William Tai-Wei
DirectorPRESIDENT AND CEO10% Owner
Transactions
  • Award

    Series A Warrants (right to buy)

    2024-10-04+81,967→ 81,967 total
    Exercise: $0.45Exp: 2025-10-04→ Common Stock (81,967 underlying)
  • Award

    Series C Warrants (right to buy)

    2024-10-04+126,582→ 126,582 total
    Exercise: $0.27Exp: 2027-10-04→ Common Stock (126,582 underlying)
  • Disposition to Issuer

    Series A Warrants (right to buy)

    2024-10-04−81,967→ 0 total
    Exercise: $1.25Exp: 2025-06-13→ Common Stock (81,967 underlying)
  • Award

    Common Stock

    2024-10-04+126,582→ 2,548,094 total
Holdings

  • Common Stock

    (indirect: By Children)
    73,000

  • Common Stock

    (indirect: See footnote)
    36,500

  • Common Stock

    (indirect: By Children)
    72,999

  • Common Stock

    (indirect: See footnote)
    36,500

  • Common Stock

    (indirect: See footnote)
    36,500
Footnotes (5)
  • [F1]The reported securities are included within 126,582 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 126,582 shares of common stock.
  • [F2]The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy.
  • [F3]The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.
  • [F4]Fully vested and exercisable.
  • [F5]The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.

Documents

1 file

Issuer

IN8BIO, INC.

CIK 0001740279

→
Entity typeother

Related Parties

1
  • filerCIK 0001830914

Filing Metadata

Form type
4
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 4:15 PM ET
Size
16.2 KB
View on SEC.gov